Trehan’s hospital achieves fin closure

fe Bureau
Posted: Friday, Jul 10, 2009 at 0022 hrs IST
Updated: Friday, Jul 10, 2009 at 0022 hrs IST

Font Size

Feedback

Discuss

Banks likely to retain home loan rates PSBs outperform private banks in Q2 BoB net up 60% to Rs 634 cr SBI eyes second buy in Indonesia

Mumbai: YES Bank has announced the financial closure of Rs 500 crore project finance for Medanta—the Medicity Super specialty Tertiary Care Hospital promoted by Naresh Trehan.

YES Bank was appointed as sole underwriter and mandated lead arranger for raising debt for Medanta. The other members that participated in this syndication for funding Medanta were Allahabad Bank, Dena Bank, Punjab & Sind Bank and State Bank of Hyderabad. The syndication process was completed within 60 days of its launch. The project envisages construction of a 1,250 bed facility in Gurgaon at a total cost of Rs 932 crore to be funded at a debt - equity ratio of 1.10x. The hospital is at an advanced stage of completion, expected to commence operations from October 1, 2009.

Rana Kapoor, founder, managing director & CEO, YES Bank, said, “YES Bank has evolved from an established provider of debt capital to a facilitator and arranger of capital raising and has assisted clients in obtaining superior financial returns in a risk-mitigated, well structured manner. This exceptional project financing further demonstrates our knowledge driven approach with a concerted focus on the Healthcare and Life sciences sector, and we are fully committed to partner healthcare providers to facilitate the growth and development of this key sector.”

The value of the current Indian healthcare market is about Rs 1, 50,000 crore, and is expected to grow at a compound annual growth rate of 12-15% over the next decade. Indian healthcare market is expected to contribute 8% to the GDP and generate employment opportunities for nine million people by 2012. Private healthcare is expected to garner approximately 60% of the estimated Rs 2,50,000 crore healthcare market by 2012.

Post Comments

Comments: (Limit 3,000 characters)

Name		Message
Email ID
Subject

TERMS OF USE:
The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).

I agree to the terms of use.